• Worst Pills, Best Pills



• Health Letter



• Health Links



• Activist Courses



• Take Action!



• Drug Safety



• Healthcare Delivery



• Medical Devices



• Food Safety



• Occupational Health

Publications:

» (10/2/08) Testimony before FDA hearing on cough and cold remedies for children (HRG Publication #1845) » (10/17/05) Misleading data analyses in salmeterol (SMART) study (HRG Publication #1752) » (10/15/01) Letter urging the FDA to reject drug industry's request for liability disclaimer in its withdrawal of products containing phenylpropanolamine (PPA) (HRG Publication #1596) » (8/9/01) Letter to HHS that supports a criminal investigation of Schering-Plough based on the possibility that the company knowingly shipped millions of asthma drug inhalers that may not have contained any active ingredients. (HRG Publication #1586) » (11/22/00) Letter to the National Institute for Clinical Excellence urging it to reconsider recommendations concerning Relenza use among people in the United Kingdom. (HRG Publication #1547) » (10/19/00) Testimony before the Food and Drug Administration NonPrescription Drugs Advisory Committee Meeting on Safety Issues of Phenylpropanolamine/PPA. (HRG Publication #1541)

more resources

Because Public Citizen does not accept funds from corporations, professional associations or government agencies, we can remain independent and follow the truth wherever it may lead. But that means we depend on the generosity of concerned citizens like you for the resources to fight on behalf of the public interest. If you would like to help us in our fight, click here.